Biotech10 months ago
Eli Lilly Beats Q1 Estimates, Raises 2024 Targets
Eli Lilly's first-quarter results exceeded expectations, with a $8.77 billion turnover, a 26% year-on-year growth, and $2.24 billion net income, 67% higher than in 2023. Strong...